Clinical trials
Genetic Predisposition to Disease trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 6 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brigham and Women's Hospital | 5 |
| Abramson Cancer Center at Penn Medicine | 2 |
| Dana-Farber Cancer Institute | 2 |
| University of Virginia | 2 |
| Boston Children's Hospital | 1 |
| Carilion Clinic | 1 |
| Children's Hospital of Philadelphia | 1 |
| Christopher Reilly | 1 |
| Georgetown University | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genetic Predisposition to Disease | 28 |
| Genetic Diseases, Inborn | 6 |
| Alzheimer Disease | 3 |
| Breast Neoplasms | 3 |
| Disease Susceptibility | 3 |
| Ovarian Neoplasms | 3 |
| Neoplasms | 2 |
| Parkinson Disease | 2 |
| Aortic Aneurysm, Thoracic | 1 |
| Basal Ganglia Diseases | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.